SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-069070
Filing Date
2024-06-06
Accepted
2024-06-06 16:06:22
Documents
14
Period of Report
2024-06-06
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2416636d1_8k.htm   iXBRL 8-K 41798
2 EXHIBIT 3.1 tm2416636d1_ex3-1.htm EX-3.1 10227
  Complete submission text file 0001104659-24-069070.txt   233745

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bdtx-20240606.xsd EX-101.SCH 3063
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdtx-20240606_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdtx-20240606_pre.xml EX-101.PRE 22391
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2416636d1_8k_htm.xml XML 3817
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39200 | Film No.: 241025045
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)